Related Experiment Videos
The serotonergic system in Parkinson's disease
Philippe Huot1, Susan H Fox, Jonathan M Brotchie
1Toronto Western Research Institute, MCL 11-419, Toronto Western Hospital, University Health Network, 399 Bathurst Street, Toronto, Ontario, Canada M5T 2S8.
Progress in Neurobiology
|September 1, 2011
Summary
Parkinson's disease (PD) involves more than just dopamine loss; the serotonin system (5-HT) is also altered, impacting non-motor symptoms and treatments. Further research is needed to fully understand these complex 5-HT roles in PD.
Area of Science:
- Neuroscience
- Pharmacology
- Neurology
Background:
- Parkinson's disease (PD) is primarily linked to striatal dopamine depletion.
- Non-motor symptoms and treatment complications in PD are increasingly associated with the serotonergic system.
- Altered serotonin (5-HT) neurotransmission is a recognized feature in Parkinson's disease.
Purpose of the Study:
- To comprehensively review preclinical and clinical studies on the serotonergic system in PD.
- To summarize current knowledge regarding the role of different serotonin (5-HT) receptor subtypes in PD.
- To identify research gaps and areas requiring further investigation in PD and its animal models.
Main Methods:
- Systematic literature review of preclinical studies.
- Systematic literature review of clinical studies.
- Analysis of studies investigating 5-HT receptor subtypes in PD and animal models.
Main Results:
- The serotonergic system, particularly various 5-HT receptor subtypes, is significantly implicated in PD.
- Altered 5-HT neurotransmission contributes to both motor and non-motor aspects of Parkinson's disease.
- Evidence suggests a critical role for the serotonergic system in treatment-related complications.
Conclusions:
- The serotonergic system is a key player in Parkinson's disease pathophysiology beyond dopamine.
- Understanding 5-HT receptor involvement is crucial for developing comprehensive PD treatments.
- Further research is warranted to elucidate the precise mechanisms and therapeutic potential of targeting the 5-HT system in PD.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...